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95% CI=1.3-2.5) tsetse, were positive for T. brucei s.l.. Of these samples 24 cattle (61.5%), 15 pig (60%) and 23 25 tsetse (62.5%) samples had sufficient DNA to be screened using the T. brucei sub-species PCR. Further 24 analysis found no cattle or pigs positive for T. b. gambiense, however, 17/40 of the tsetse samples 25 produced a band suggestive of T. b. gambiense. When three of these 17 PCR products were sequenced the 26 sequences were markedly different to T. b. gambiense, indicating that these flies were not infected with T. 27 b. gambiense. 28 Conclusion 29 The absence of T. b. gambiense in cattle, pigs and tsetse accords with the low prevalence of g-HAT in the 30 human population. We found no evidence that livestock are acting as reservoir hosts. However, this study 31 highlights the limitations of current methods of detecting and identifying T. b. gambiense which relies on a 32 single copy-gene to discriminate between the different sub-species of T. brucei s.l. 33 Author Summary 34 The decline of annual cases of West-African sleeping sickness in Uganda raises the prospect that 35 elimination of the disease is achievable for the country. However, with the decrease in incidence and the 36 likely subsequent change in priorities there is a need to confirm that the disease is truly eliminated. One 37 unanswered question is the role that domestic animals play in maintaining transmission of the disease. The 38 potential of cryptic-animal reservoirs is a serious threat to successful and sustained elimination of the 39 disease. It is with the intent of resolving this question that we have carried out this study whereby we 40 examined 2088 cattle, 400 pigs and 2184 tsetse for Trypanosoma brucei gambiense, the parasite 41 responsible for the disease. Our study found T. brucei s.l. in local cattle, pigs and tsetse flies, with their 42 respective prevalences as follows, 1.9%, 6.3% and 1.8%. Further analysis to establish identity of these 43 positives to the sub-species level found that no cattle, pigs or tsetse were carrying the pathogen 44 responsible for Gambian sleeping sickness. Our work highlights the difficulty of establishing the absence of Introduction 48 The term "human African trypanosomiasis" (HAT) is used to describe two diseases that are clinically, geographically 49 and parasitological distinct. 
119
Of the tsetse caught, 6,664 were dissected at the field laboratory (333842N-269418E) to screen for trypanosomes in 120 their mouthparts, salivary glands and midguts (29). Following their dissection, the three tissue types (mouthparts, 121 salivary glands and midguts) were screened for trypanosomes at x400 using a compound-microscope with a dark-122 field filter. Both negative and positive tissues were then preserved, individually, in 100% ethanol, on a 96 well plate, 123 for further molecular analysis. Of the 6,664-tsetse preserved in this manner 2,184 were processed using the 124 molecular methods described below. The sub-sample of tsetse was selected based on the season they were caught, 125 with samples from the wet and dry season of Septemeber2013-February 2014 being chosen. 190 congolense Forest). The products for T. brucei s.l. and T. vivax measure 342bp and 139bp, respectively (Fig. 3) . Unpublished 209 *The size range of the T. congolense products varied depending on the strain type with Kilifi producing a smaller 210 product of 392bp in size compared to both the Savannah and Forest strains producing a product of 433bp in size.
212
However as there is a difference in the copy number being targeted by the different primers not all those samples 213 initially identified as T. brucei s.l. will be identified down to a sub-species level due to insufficient DNA. Following the 214 detection of T. brucei s.l. positive samples using either the multiplex ITS primers or the FIND TBR-PCR primers (30) to the difficulty of reliably amplifying a single copy gene, and therefore the low sensitivity of the two sub-species 228 specific assays, there is a chance that a negative result occurs due to insufficient target DNA. To help increase the 229 confidence of a negative result it is possible to determine if there is sufficient quantity of DNA by running an assay 230 that amplifies a single copy gene ubiquitous to all three sub-species. The multiplex designed by Picozzi et al (17) In total 38/2,877 (1.3%; 95% CI=0.9-1.8) cattle and 25/400 (6.3%; 95% CI=4.1-9.1) pigs examined using the Of the 2,184 samples screened with multiplex ITS primers, trypanosomes were observed by microscopy in 274 62 samples (49 flies), comprising 30 midguts, four salivary glands and 28 mouthparts. Of the microscopy 275 positives the molecular assay identified 48 of 62 positive tissues, (Table 5) . 
300
Of the 17 bands, a subsample of three were sent for sequencing to determine the specific product size and 301 sequence. The samples were sent to SourceBioscience using both forward and reverse primers. The results 302 of the sequencing showed that the three bands sent were identical and that the product was 281 bp to the expected band size for T. b. gambiense. However sequencing results showed that the size of the product 320 generated by the samples was smaller than the expected size at only 281bp compared to the expected 308bp sized 321 product. There was also significant variation in the 281bp sized sequences compared to T. b. gambiense sequence.
322
Based on the sequencing results these positive samples cannot be unequivocally identified as T. b. gambiense.
323
Three conclusions arise from the tsetse survey, the first is that despite screening 2,184 tsetse, no tsetse were found 324 to be positive for T. brucei gambiense, this could be due to T. b. gambiense no longer being transmitted in the area or that our sample size was too small to detect T. b. gambiense. Despite being understood as the sole vector of gHAT 326 (39) the prevalence of the disease amongst wild tsetse population is often extremely low (1, 40, 41) The diagnostic methods used in this paper involved both microscopy and PCR, of which only PCR has the potential to 358 discriminate sub-species of T. b. gambiense (17, 34) . There are few diagnostic methods that are capable of 359 accurately distinguishing between the T. brucei sub-species (16, 17, 34) . The molecular methods available for the 360 detection of T. b. gambiense are limited due to the practical aspect of conducting these assays in the field and the 361 limited diagnostic markers available. As mentioned previously the sensitivity of T. b. gambiense specific PCR is 362 limited to detecting a single copy gene. Some molecular assays attempt to overcome this problem by relying on the 363 human serums ability to lyse all salivarian trypanosomes (except for T. b. gambiense and T. b. rhodesiense) therefore 364 any T. brucei s.l. identified in a human sample would be one of the two HAT species (45). This allows for the targeting 365 of a higher copy region specific to the T. brucei species group. Using this method any positives would have to be one 366 of the two HAT species, however as the treatment of the two diseases differs and the only option to try and identify 367 if it was an East or West African sleeping sickness infection would be to try and determine the geographical location 368 of where the individual was infected. This approach would also only be limited to humans and could not be used in 369 either xenodiagnoses or screening animals, as all three T. brucei sub-species could be present in the vector or animal 370 populations. To put these differences of sensitivity in perspective, we can look at the limit of detection (LoD) of the 371 number of trypanosome per mL, between multiple diagnostic methods ( The lack of a highly specific, sensitive and field-friendly assay that is capable of screening for T. b. gambiense in both 375 the human, vector and local animal populations is sorely needed if the hope of eliminating sleeping sickness by 2020 376 is to be achieved. (47). This study also highlights the lack of highly sensitive diagnostics that can 382 discriminate between the different sub-species of T. brucei s.l.. Despite not finding T. b. gambiense in the tsetse 383 population of Koboko vector control has been calculated to being essential to reach the elimination goal of 2030 (48) 384
